Related Experiment Video
Updated: Feb 2, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Luteolin exerts an anticancer effect on gastric cancer cells through multiple signaling pathways and regulating
Yansong Pu1, Tao Zhang1, Jianhua Wang1
1The Second Department of General Surgery, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068, P.R. China.
Abstract:
Accumulating studies confirmed that luteolin, a common dietary flavonoid which is widely distributed in plants and has diverse beneficial biological function, including anti-oxidant, anti-inflammation and anticancer properties. However, the detail mechanisms of luteolin on GC are poorly understood. Here, we investigated the anticancer effect of luteolin in GC cells in vitro and in vivo. Luteolin reduced the cell viability in a time and dose-dependent manner. Luteolin significantly inhibited cell cycle progress, colony formation, proliferation, migration, invasion and promoted apoptosis in vitro and in vivo. Luteolin also regulated these biological effects associated regulators. Mechanically, luteolin treatment regulated Notch1, PI3K, AKT, mTOR, ERK, STAT3 and P38 signaling pathways and modulated a series of miRNAs expression. These findings provide novel insight into the molecular function of luteolin which suggest its potential as a therapeutic agent for human GC.
Insights
Luteolin, a plant flavonoid, demonstrates significant anticancer effects against gastric cancer (GC) by inhibiting cell viability and promoting apoptosis. This study explores its molecular mechanisms, revealing potential therapeutic applications for GC treatment.
Area of Science:
- Molecular Biology
- Pharmacology
- Oncology
Background:
- Luteolin is a dietary flavonoid with known antioxidant, anti-inflammatory, and anticancer properties.
- The precise mechanisms of luteolin's action against gastric cancer (GC) remain largely unelucidated.
- Understanding luteolin's molecular targets is crucial for developing novel GC therapies.
Purpose of the Study:
- To investigate the anticancer effects of luteolin on gastric cancer (GC) cells.
- To elucidate the underlying molecular mechanisms of luteolin's anti-GC activity.
- To assess the therapeutic potential of luteolin as an agent for human GC.
Main Methods:
- Evaluated luteolin's impact on GC cell viability, proliferation, apoptosis, migration, and invasion in vitro and in vivo.
- Analyzed the regulation of key signaling pathways including Notch1, PI3K/AKT/mTOR, ERK, STAT3, and p38.
- Investigated the modulation of microRNA (miRNA) expression profiles following luteolin treatment.
Main Results:
- Luteolin significantly reduced GC cell viability, proliferation, migration, and invasion in a dose- and time-dependent manner.
- Luteolin treatment promoted apoptosis in GC cells.
- Luteolin modulated multiple signaling pathways (Notch1, PI3K/AKT/mTOR, ERK, STAT3, p38) and altered miRNA expression.
Conclusions:
- Luteolin exhibits potent anticancer effects against gastric cancer through multifaceted molecular mechanisms.
- The study provides novel insights into luteolin's molecular functions in regulating GC progression.
- Luteolin shows promise as a potential therapeutic agent for human gastric cancer.
Related Concept Videos
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Expression at Multiple Steps
Non-Canonical Wnt Signaling Pathways

